Skip to main content
. 2008 Sep 4;38(10):661–669. doi: 10.1093/jjco/hyn089

Table 5.

Multivariate analysis of disease-free survival and overall survival in Stages II and III (n = 103)a

Prognostic factors Disease-free survival
Overall survival
HR 95% CI P valueb HR 95% CI P valueb
Age
 ≤62c 1.00 1.00
 >62 1.40 0.84–2.34 0.202 2.06 1.21–3.53 0.008
Histologic type
 Squamous 1.00 1.00
 Non-squamous 2.84 1.65–4.89 <0.0001 1.75 0.99–3.07 0.052
Tumor size (cm)
 ≤3.9d 1.00 1.00
 >3.9 2.00 1.26–3.20 0.004 1.94 1.18–3.19 0.009
Stagee
 II 1.00 1.00
 IIIA 1.51 0.91–2.49 0.110 1.66 0.96–2.86 0.069
 IIIB 1.83 0.93–3.57 0.079 2.29 1.15–4.56 0.019
Resection margin
 Negative 1.00 1.00
 Positive 2.07 1.04–4.13 0.039 2.21 1.10–4.44 0.026
Chemotherapy
 Yes 1.00 1.00
 No 1.55 0.98–2.45 0.061 1.47 0.89–2.45 0.136
Expression of Bax
 High 1.00 1.00
 Low 2.51 1.35–4.66 0.004 1.77 0.92–3.40 0.086

aExcluding five patients who died of post-operative complication. bCox proportional-hazards regression model. cMedian age. dMedian longest diameter of primary tumor. ePost-operative pathologic staging.